Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYALURONIDASE Cause Peripheral venous disease? 177 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Peripheral venous disease have been filed in association with HYALURONIDASE (Phesgo). This represents 16.0% of all adverse event reports for HYALURONIDASE.

177
Reports of Peripheral venous disease with HYALURONIDASE
16.0%
of all HYALURONIDASE reports
174
Deaths
177
Hospitalizations

How Dangerous Is Peripheral venous disease From HYALURONIDASE?

Of the 177 reports, 174 (98.3%) resulted in death, 177 (100.0%) required hospitalization, and 177 (100.0%) were considered life-threatening.

Is Peripheral venous disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 177 reports have been filed with the FAERS database.

What Other Side Effects Does HYALURONIDASE Cause?

Fatigue (375) Alopecia (358) Abdominal discomfort (355) Arthralgia (349) Diarrhoea (330) Headache (328) Hypertension (325) Blood cholesterol increased (320) Arthropathy (318) Off label use (315)

What Other Drugs Cause Peripheral venous disease?

RITUXIMAB (1,281) ADALIMUMAB (1,249) METHOTREXATE (1,246) SECUKINUMAB (1,186) ABATACEPT (1,168) DICLOFENAC (1,168) LEFLUNOMIDE (1,154) TOCILIZUMAB (1,137) PREDNISONE (1,101) ALENDRONATE (1,097)

Which HYALURONIDASE Alternatives Have Lower Peripheral venous disease Risk?

HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB HYALURONIDASE vs HYALURONIDASE \RITUXIMAB HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HYALURONIDASE vs HYDRALAZINE HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE

Related Pages

HYALURONIDASE Full Profile All Peripheral venous disease Reports All Drugs Causing Peripheral venous disease HYALURONIDASE Demographics